pCDH-EF1-copGFP-T2A-Puro Citations (23)
Originally described in: lenti vectorUnpublished
Articles Citing pCDH-EF1-copGFP-T2A-Puro
| Articles |
|---|
| Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor. Gong Y, Klein Wolterink RGJ, Janssen I, Groot AJ, Bos GMJ, Germeraad WTV. Mol Ther Methods Clin Dev. 2020 Mar 29;17:634-646. doi: 10.1016/j.omtm.2020.03.017. eCollection 2020 Jun 12. PubMed |
| Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8(+) T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy. Weulersse M, Asrir A, Pichler AC, Lemaitre L, Braun M, Carrie N, Joubert MV, Le Moine M, Do Souto L, Gaud G, Das I, Brauns E, Scarlata CM, Morandi E, Sundarrajan A, Cuisinier M, Buisson L, Maheo S, Kassem S, Agesta A, Peres M, Verhoeyen E, Martinez A, Mazieres J, Dupre L, Gossye T, Pancaldi V, Guillerey C, Ayyoub M, Dejean AS, Saoudi A, Goriely S, Avet-Loiseau H, Bald T, Smyth MJ, Martinet L. Immunity. 2020 Oct 13;53(4):824-839.e10. doi: 10.1016/j.immuni.2020.09.006. PubMed |
| A reporter system for enriching CRISPR/Cas9 knockout cells in technically challenging settings like patient models. Liu WH, Volse K, Senft D, Jeremias I. Sci Rep. 2021 Jun 16;11(1):12649. doi: 10.1038/s41598-021-91760-9. PubMed |
| The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy. Wei G, Sun H, Dong K, Hu L, Wang Q, Zhuang Q, Zhu Y, Zhang X, Shao Y, Tang H, Li Z, Chen S, Lu J, Wang Y, Gan X, Zhong TP, Gui D, Hu X, Wang L, Liu J. Cell Metab. 2021 Oct 5;33(10):2021-2039.e8. doi: 10.1016/j.cmet.2021.08.012. Epub 2021 Sep 10. PubMed |
| CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization. Hong X, Li Q, Li J, Chen K, He Q, Zhao Y, Liang Y, Zhao Y, Qiao H, Liu N, Ma J, Li Y. Clin Cancer Res. 2022 Oct 14;28(20):4521-4535. doi: 10.1158/1078-0432.CCR-22-0991. PubMed |
| Loss of VOPP1 Contributes to BET Inhibitor Acquired Resistance in Non-Small Cell Lung Cancer Cells. Sun L, Wu Q, Huan XJ, Tian CQ, Wang YQ, Miao ZH. Mol Cancer Res. 2022 Dec 2;20(12):1785-1798. doi: 10.1158/1541-7786.MCR-21-1000. PubMed |
| Cell-intrinsic differences between human airway epithelial cells from children and adults. Maughan EF, Hynds RE, Pennycuick A, Nigro E, Gowers KHC, Denais C, Gomez-Lopez S, Lazarus KA, Orr JC, Pearce DR, Clarke SE, Lee DDH, Woodall MNJ, Masonou T, Case KM, Teixeira VH, Hartley BE, Hewitt RJ, Al Yaghchi C, Sandhu GS, Birchall MA, O'Callaghan C, Smith CM, De Coppi P, Butler CR, Janes SM. iScience. 2022 Oct 20;25(11):105409. doi: 10.1016/j.isci.2022.105409. eCollection 2022 Nov 18. PubMed |
| CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic Cancer. Jacoberger-Foissac C, Cousineau I, Bareche Y, Allard D, Chrobak P, Allard B, Pommey S, Messaoudi N, McNicoll Y, Soucy G, Koseoglu S, Masia R, Lake AC, Seo H, Eeles CB, Rohatgi N, Robson SC, Turcotte S, Haibe-Kains B, Stagg J. Cancer Immunol Res. 2023 Jan 3;11(1):56-71. doi: 10.1158/2326-6066.CIR-22-0260. PubMed |
| Incorporating a Polyethyleneglycol Linker to Enhance the Hydrophilicity of Mitochondria-Targeted Triphenylphosphonium Constructs. Uno S, Harkiss AH, Chowdhury R, Caldwell ST, Prime TA, James AM, Gallagher B, Prudent J, Hartley RC, Murphy MP. Chembiochem. 2023 Jun 1;24(11):e202200774. doi: 10.1002/cbic.202200774. Epub 2023 May 4. PubMed |
| Cis-regulatory atlas of primary human CD4+ T cells. Stefan K, Barski A. BMC Genomics. 2023 May 11;24(1):253. doi: 10.1186/s12864-023-09288-3. PubMed |
| RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer. Li YQ, Sun FZ, Li CX, Mo HN, Zhou YT, Lv D, Zhai JT, Qian HL, Ma F. Mil Med Res. 2023 Jul 25;10(1):34. doi: 10.1186/s40779-023-00470-y. PubMed |
| In vitro formation and extended culture of highly metabolically active and contractile tissues. Bagdasarian IA, Tonmoy TI, Park BH, Morgan JT. PLoS One. 2023 Nov 1;18(11):e0293609. doi: 10.1371/journal.pone.0293609. eCollection 2023. PubMed |
| Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer. Niu N, Shen X, Wang Z, Chen Y, Weng Y, Yu F, Tang Y, Lu P, Liu M, Wang L, Sun Y, Yang M, Shen B, Jin J, Lu Z, Jiang K, Shi Y, Xue J. Cancer Cell. 2024 May 13;42(5):869-884.e9. doi: 10.1016/j.ccell.2024.03.005. Epub 2024 Apr 4. PubMed |
| Zonal Patterning of Extracellular Matrix and Stromal Cell Populations Along a Perfusable Cellular Microchannel. Chernokal B, Ferrick BJ, Gleghorn JP. bioRxiv [Preprint]. 2024 Jul 9:2024.07.09.602744. doi: 10.1101/2024.07.09.602744. PubMed |
| TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer. Li S, Hu G, Chen Y, Sang Y, Tang Q, Liu R. Cancer Cell Int. 2024 Aug 3;24(1):271. doi: 10.1186/s12935-024-03459-2. PubMed |
| Colchicine-mediated selective autophagic degradation of HBV core proteins inhibits HBV replication and HBV-related hepatocellular carcinoma progression. Zhang H, Su X, Gu L, Tan M, Liu Y, Xu K, Ren J, Chen J, Li Z, Cheng S. Cell Death Discov. 2024 Aug 6;10(1):352. doi: 10.1038/s41420-024-02122-z. PubMed |
| Zonal patterning of extracellular matrix and stromal cell populations along a perfusable cellular microchannel. Chernokal B, Ferrick BJ, Gleghorn JP. Lab Chip. 2024 Nov 19;24(23):5238-5250. doi: 10.1039/d4lc00579a. PubMed |
| CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells. Zhou S, Lin W, Jin X, Niu R, Yuan Z, Chai T, Zhang Q, Guo M, Kim SS, Liu M, Deng Y, Park JB, Choi SI, Shi B, Yin J. Cell Rep Med. 2024 Dec 17;5(12):101844. doi: 10.1016/j.xcrm.2024.101844. Epub 2024 Dec 4. PubMed |
| RhoB regulates prostate cancer cell proliferation and docetaxel sensitivity via the PI3K-AKT signaling pathway. Sheng T, Su H, Yao L, Qu Z, Liu H, Shao W, Zhang X. BMC Cancer. 2025 Feb 26;25(1):354. doi: 10.1186/s12885-025-13762-4. PubMed |
| L-methionine promotes CD8(+) T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling. Yuan C, Hu C, Zhou H, Liu W, Lai W, Liu Y, Yin Y, Li G, Zhang R. Neoplasia. 2025 Jun;64:101160. doi: 10.1016/j.neo.2025.101160. Epub 2025 Mar 29. PubMed |
| NRF1-Induced lncRNA DDX11-AS1 Contributes to the Progression of Hepatocellular Carcinoma via Activating CA9 Expression and the MEK/ERK Pathway. Li Y, Shi M, Bie B, Tian H, Li J, Li Z, Sun J. J Hepatocell Carcinoma. 2025 May 7;12:891-908. doi: 10.2147/JHC.S516656. eCollection 2025. PubMed |
| FRMD8 inhibits tumor metastasis in BRCA1-associated TNBC by negatively regulating tmTNF-alpha. Xu J, Yang X, Shu P, Wang W, Wu H, Wang Z. Cell Mol Biol Lett. 2025 Jul 6;30(1):76. doi: 10.1186/s11658-025-00754-2. PubMed |
| Targeting SQLE-mediated cholesterol metabolism to enhance CD8(+) T cell activation and immunotherapy efficacy in hepatocellular carcinoma. Qiao S, Zou H, Weng Y, Liu YF, Li W, Yu XJ, Li L, Zheng L, Xu J. J Immunother Cancer. 2025 Sep 26;13(9):e012345. doi: 10.1136/jitc-2025-012345. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.